LUXEMBOURG--(BUSINESS WIRE)--Regulatory News: Eurofins Scientific SE (Paris:ERF): Outlook and financial objectives Comments from the CEO, Dr. Gilles Martin: “The results of the first half of 2022 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback